Back to News
Market Impact: 0.25
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
A new class-action lawsuit against Hims & Hers (HIMS) is urging investors to seek recovery for alleged securities-fraud violations, with a November 1, 2026 deadline to apply as lead plaintiff. The article provides no details on the alleged misconduct, damages, or potential financial exposure, but the litigation introduces reputational and legal risk for the company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
HIMS-0.85
More News
- HIMS DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action
- Biotech stocks are surging. How investors can play the new drug innovation boom
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- Thousands of Israelis rally against Netanyahu gov’t days before election
- J&J prostate cancer drug shows promising tumor responses in early trial
- Pfizer reports phase 2 data for 25-valent pneumococcal vaccine